Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Pharma
Eli Lilly's tirzepatide excels in phase 3 sleep apnea studies
Two trials have shown that Eli Lilly’s weight loss product Zepbound (tirzepatide) can help patients overcome obstructive sleep apnea (OSA).
Kevin Dunleavy
Apr 17, 2024 11:04am
Lilly’s edge over rivals tipped to drive Mounjaro sales to $34B
Apr 17, 2024 10:45am
Lilly, plaintiffs cancel $13.5M insulin pricing settlement
Apr 17, 2024 7:00am
Inside #FierceMadness winner Wainua's 'phonetic appeal'
Apr 15, 2024 4:16pm
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am
Lilly's Mounjaro will be in short supply through April, FDA says
Apr 2, 2024 5:12pm